LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

RNA ligase (ATP)

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
RNA ligase (ATP)
Gene product:
KREL1
Species:
Leishmania braziliensis
UniProt:
A4H382_LEIBR
TriTrypDb:
LbrM.01.0620 , LBRM2903_010011400 *
Length:
424

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 22
NetGPI no yes: 0, no: 22
Cellular components
Term Name Level Count
GO:0031019 mitochondrial mRNA editing complex 3 1
GO:0032991 protein-containing complex 1 1
GO:0045293 mRNA editing complex 3 1
GO:0098798 mitochondrial protein-containing complex 2 1
GO:1902494 catalytic complex 2 1

Expansion

Sequence features

A4H382
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A4H382

Function

Biological processes
Term Name Level Count
GO:0006139 nucleobase-containing compound metabolic process 3 1
GO:0006725 cellular aromatic compound metabolic process 3 1
GO:0006807 nitrogen compound metabolic process 2 1
GO:0008152 metabolic process 1 1
GO:0009451 RNA modification 5 1
GO:0009987 cellular process 1 1
GO:0016070 RNA metabolic process 5 1
GO:0034641 cellular nitrogen compound metabolic process 3 1
GO:0043170 macromolecule metabolic process 3 1
GO:0043412 macromolecule modification 4 1
GO:0044237 cellular metabolic process 2 1
GO:0044238 primary metabolic process 2 1
GO:0046483 heterocycle metabolic process 3 1
GO:0071704 organic substance metabolic process 2 1
GO:0090304 nucleic acid metabolic process 4 1
GO:1901360 organic cyclic compound metabolic process 3 1
Molecular functions
Term Name Level Count
GO:0000166 nucleotide binding 3 23
GO:0003824 catalytic activity 1 23
GO:0003972 RNA ligase (ATP) activity 5 23
GO:0005488 binding 1 23
GO:0005524 ATP binding 5 23
GO:0008452 RNA ligase activity 4 23
GO:0016874 ligase activity 2 23
GO:0016886 ligase activity, forming phosphoric ester bonds 3 23
GO:0017076 purine nucleotide binding 4 23
GO:0030554 adenyl nucleotide binding 5 23
GO:0032553 ribonucleotide binding 3 23
GO:0032555 purine ribonucleotide binding 4 23
GO:0032559 adenyl ribonucleotide binding 5 23
GO:0035639 purine ribonucleoside triphosphate binding 4 23
GO:0036094 small molecule binding 2 23
GO:0043167 ion binding 2 23
GO:0043168 anion binding 3 23
GO:0097159 organic cyclic compound binding 2 23
GO:0097367 carbohydrate derivative binding 2 23
GO:0140098 catalytic activity, acting on RNA 3 23
GO:0140640 catalytic activity, acting on a nucleic acid 2 23
GO:1901265 nucleoside phosphate binding 3 23
GO:1901363 heterocyclic compound binding 2 23

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 22 26 PF00656 0.525
CLV_C14_Caspase3-7 409 413 PF00656 0.372
CLV_NRD_NRD_1 244 246 PF00675 0.409
CLV_NRD_NRD_1 28 30 PF00675 0.492
CLV_NRD_NRD_1 377 379 PF00675 0.414
CLV_NRD_NRD_1 95 97 PF00675 0.416
CLV_PCSK_KEX2_1 136 138 PF00082 0.378
CLV_PCSK_KEX2_1 244 246 PF00082 0.344
CLV_PCSK_KEX2_1 28 30 PF00082 0.481
CLV_PCSK_KEX2_1 398 400 PF00082 0.477
CLV_PCSK_KEX2_1 62 64 PF00082 0.317
CLV_PCSK_KEX2_1 95 97 PF00082 0.472
CLV_PCSK_PC1ET2_1 136 138 PF00082 0.378
CLV_PCSK_PC1ET2_1 398 400 PF00082 0.487
CLV_PCSK_PC1ET2_1 62 64 PF00082 0.317
CLV_PCSK_PC1ET2_1 95 97 PF00082 0.315
CLV_PCSK_PC7_1 394 400 PF00082 0.285
CLV_PCSK_SKI1_1 106 110 PF00082 0.323
CLV_PCSK_SKI1_1 125 129 PF00082 0.463
CLV_PCSK_SKI1_1 29 33 PF00082 0.264
CLV_PCSK_SKI1_1 298 302 PF00082 0.531
CLV_PCSK_SKI1_1 360 364 PF00082 0.430
CLV_PCSK_SKI1_1 378 382 PF00082 0.353
CLV_PCSK_SKI1_1 59 63 PF00082 0.279
DOC_CDC14_PxL_1 216 224 PF14671 0.411
DOC_CKS1_1 215 220 PF01111 0.325
DOC_MAPK_gen_1 260 269 PF00069 0.401
DOC_MAPK_gen_1 293 302 PF00069 0.593
DOC_PP1_RVXF_1 381 388 PF00149 0.439
DOC_PP4_FxxP_1 215 218 PF00568 0.325
DOC_USP7_MATH_1 61 65 PF00917 0.342
DOC_USP7_UBL2_3 270 274 PF12436 0.501
DOC_USP7_UBL2_3 360 364 PF12436 0.431
DOC_WW_Pin1_4 151 156 PF00397 0.273
DOC_WW_Pin1_4 214 219 PF00397 0.325
LIG_14-3-3_CanoR_1 262 267 PF00244 0.394
LIG_14-3-3_CanoR_1 405 415 PF00244 0.526
LIG_APCC_ABBA_1 107 112 PF00400 0.447
LIG_APCC_ABBA_1 177 182 PF00400 0.315
LIG_APCC_ABBAyCdc20_2 106 112 PF00400 0.447
LIG_BRCT_BRCA1_1 146 150 PF00533 0.414
LIG_BRCT_BRCA1_1 373 377 PF00533 0.501
LIG_BRCT_BRCA1_1 383 387 PF00533 0.455
LIG_BRCT_BRCA1_2 373 379 PF00533 0.497
LIG_Clathr_ClatBox_1 177 181 PF01394 0.447
LIG_DLG_GKlike_1 262 269 PF00625 0.409
LIG_FHA_1 117 123 PF00498 0.376
LIG_FHA_1 364 370 PF00498 0.556
LIG_FHA_1 82 88 PF00498 0.364
LIG_FHA_2 12 18 PF00498 0.393
LIG_FHA_2 20 26 PF00498 0.513
LIG_FHA_2 201 207 PF00498 0.382
LIG_FHA_2 279 285 PF00498 0.502
LIG_FHA_2 407 413 PF00498 0.512
LIG_Integrin_RGD_1 245 247 PF01839 0.340
LIG_LIR_Apic_2 213 218 PF02991 0.325
LIG_LIR_Gen_1 11 19 PF02991 0.423
LIG_LIR_Gen_1 126 133 PF02991 0.319
LIG_LIR_Gen_1 181 191 PF02991 0.342
LIG_LIR_Gen_1 264 272 PF02991 0.446
LIG_LIR_Nem_3 126 132 PF02991 0.382
LIG_LIR_Nem_3 147 153 PF02991 0.299
LIG_LIR_Nem_3 156 162 PF02991 0.336
LIG_LIR_Nem_3 181 186 PF02991 0.308
LIG_LIR_Nem_3 264 269 PF02991 0.424
LIG_LIR_Nem_3 396 400 PF02991 0.452
LIG_LIR_Nem_3 46 51 PF02991 0.307
LIG_LIR_Nem_3 71 76 PF02991 0.321
LIG_LIR_Nem_3 8 13 PF02991 0.441
LIG_MLH1_MIPbox_1 383 387 PF16413 0.388
LIG_MYND_3 308 312 PF01753 0.554
LIG_NRBOX 89 95 PF00104 0.340
LIG_PCNA_PIPBox_1 356 365 PF02747 0.505
LIG_PCNA_yPIPBox_3 356 364 PF02747 0.497
LIG_SH2_CRK 195 199 PF00017 0.411
LIG_SH2_CRK 76 80 PF00017 0.322
LIG_SH2_NCK_1 13 17 PF00017 0.478
LIG_SH2_STAT5 118 121 PF00017 0.349
LIG_SH2_STAT5 13 16 PF00017 0.339
LIG_SH2_STAT5 159 162 PF00017 0.462
LIG_SH2_STAT5 386 389 PF00017 0.390
LIG_SH2_STAT5 51 54 PF00017 0.314
LIG_SH3_1 118 124 PF00018 0.329
LIG_SH3_3 118 124 PF00018 0.323
LIG_SH3_3 173 179 PF00018 0.315
LIG_SUMO_SIM_anti_2 347 354 PF11976 0.399
LIG_SUMO_SIM_par_1 365 374 PF11976 0.584
LIG_TRAF2_1 33 36 PF00917 0.484
MOD_CK1_1 11 17 PF00069 0.416
MOD_CK1_1 253 259 PF00069 0.504
MOD_CK2_1 138 144 PF00069 0.483
MOD_CK2_1 166 172 PF00069 0.355
MOD_CK2_1 200 206 PF00069 0.389
MOD_CK2_1 262 268 PF00069 0.402
MOD_CK2_1 404 410 PF00069 0.427
MOD_Cter_Amidation 296 299 PF01082 0.683
MOD_GlcNHglycan 125 128 PF01048 0.362
MOD_GlcNHglycan 140 143 PF01048 0.296
MOD_GlcNHglycan 168 171 PF01048 0.325
MOD_GlcNHglycan 251 255 PF01048 0.542
MOD_GlcNHglycan 341 344 PF01048 0.325
MOD_GlcNHglycan 63 66 PF01048 0.317
MOD_GlcNHglycan 8 13 PF01048 0.566
MOD_GSK3_1 181 188 PF00069 0.416
MOD_GSK3_1 250 257 PF00069 0.517
MOD_GSK3_1 278 285 PF00069 0.494
MOD_N-GLC_1 321 326 PF02516 0.409
MOD_N-GLC_1 371 376 PF02516 0.485
MOD_N-GLC_1 53 58 PF02516 0.276
MOD_NEK2_1 261 266 PF00069 0.392
MOD_NEK2_1 278 283 PF00069 0.504
MOD_NEK2_1 371 376 PF00069 0.452
MOD_NEK2_1 381 386 PF00069 0.303
MOD_PIKK_1 185 191 PF00454 0.296
MOD_PIKK_1 404 410 PF00454 0.586
MOD_PKA_1 298 304 PF00069 0.637
MOD_PKA_2 200 206 PF00069 0.325
MOD_PKA_2 261 267 PF00069 0.389
MOD_PKA_2 27 33 PF00069 0.466
MOD_PKA_2 404 410 PF00069 0.428
MOD_Plk_1 371 377 PF00069 0.462
MOD_Plk_1 8 14 PF00069 0.518
MOD_Plk_4 254 260 PF00069 0.380
MOD_Plk_4 262 268 PF00069 0.396
MOD_Plk_4 278 284 PF00069 0.480
MOD_Plk_4 298 304 PF00069 0.547
MOD_ProDKin_1 151 157 PF00069 0.273
MOD_ProDKin_1 214 220 PF00069 0.325
MOD_SUMO_for_1 309 312 PF00179 0.598
MOD_SUMO_rev_2 264 272 PF00179 0.441
MOD_SUMO_rev_2 390 400 PF00179 0.531
TRG_DiLeu_BaEn_1 173 178 PF01217 0.342
TRG_DiLeu_BaEn_1 348 353 PF01217 0.530
TRG_DiLeu_BaLyEn_6 336 341 PF01217 0.421
TRG_ENDOCYTIC_2 13 16 PF00928 0.462
TRG_ENDOCYTIC_2 159 162 PF00928 0.454
TRG_ENDOCYTIC_2 76 79 PF00928 0.309
TRG_ER_diArg_1 243 245 PF00400 0.375
TRG_ER_diArg_1 27 29 PF00400 0.477
TRG_NLS_MonoExtC_3 134 139 PF00514 0.315
TRG_NLS_MonoExtN_4 133 139 PF00514 0.476
TRG_Pf-PMV_PEXEL_1 88 92 PF00026 0.342

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1HTX0 Leptomonas seymouri 40% 100%
A0A0N1IKD9 Leptomonas seymouri 80% 83%
A0A0S4IH84 Bodo saltans 70% 86%
A0A0S4JRM1 Bodo saltans 41% 83%
A0A1X0NW43 Trypanosomatidae 44% 100%
A0A1X0P2V9 Trypanosomatidae 74% 91%
A0A3R7NWI2 Trypanosoma rangeli 42% 100%
A0A3S5H791 Leishmania donovani 39% 100%
A0A422NFE4 Trypanosoma rangeli 75% 92%
A0A451EJB4 Leishmania donovani 92% 100%
A4HRI2 Leishmania infantum 92% 100%
A4HZ02 Leishmania infantum 39% 100%
C9ZIM1 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 42% 100%
C9ZXL1 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 74% 90%
E9AC50 Leishmania major 91% 100%
E9AIM1 Leishmania braziliensis 39% 100%
E9AJE6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 90% 100%
E9AUV4 Leishmania mexicana (strain MHOM/GT/2001/U1103) 38% 100%
P86924 Trypanosoma brucei brucei 42% 100%
P86925 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) 42% 100%
P86926 Trypanosoma brucei brucei 74% 90%
P86927 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) 74% 90%
Q6T452 Leishmania major 39% 100%
V5ASZ3 Trypanosoma cruzi 40% 100%
V5DD75 Trypanosoma cruzi 74% 85%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS